Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (831-840 of 934) with videos related to

Pageof 94
Sort By:
Circulation|January 21, 2012
Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trialShaun G Goodman, Robert Clare, Karen S Pieper, et al.
American Heart Journal|June 15, 2016
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) TrialYuichi J Shimada, Sameer Bansilal, Stephen D Wiviott, et al.
Diabetes, Obesity & Metabolism|May 19, 2022
Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysisChao Li, Jie Yu, Carinna Hockham, et al.
JACC. Cardiovascular Interventions|August 24, 2019
Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCIStefan H Hohnloser, Philippe Gabriel Steg, Jonas Oldgren, et al.
Circulation|June 3, 2004
The clinician as investigator: participating in clinical trials in the practice settingEllis W Lader, Christopher P Cannon, E Magnus Ohman, et al.
Critical Pathways in Cardiology|March 15, 2008
Assessing the effect of publication of clinical guidelines on the management of unstable angina and non-ST elevation myocardial infarction in the TIMI III (1990-1993) and the GUARANTEE (1995-1996) RegistriesBenjamin M Scirica, Christopher P Cannon, C Michael Gibson, et al.
Circulation|December 22, 1998
TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B InvestigatorsC P Cannon, C M Gibson, C H McCabe, et al.
American Heart Journal|January 8, 2025
Type 2 diabetes disease and management patterns across a large, diverse healthcare system: Issues and opportunities for guideline-directed therapiesAlexander J Blood, Lee-Shing Chang, Caitlin Colling, et al.
JAMA Cardiology|February 27, 2020
Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysisRenato D Lopes, Hwanhee Hong, Ralf E Harskamp, et al.
Journal of the American College of Cardiology|May 18, 2019
Familial Hypercholesterolemia Among Young Adults With Myocardial InfarctionAvinainder Singh, Ankur Gupta, Bradley L Collins, et al.
Pageof 94

Showing results (831-840 of 934) with videos related to

Sort By:
Pageof 94
Circulation|January 21, 2012
Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trialShaun G Goodman, Robert Clare, Karen S Pieper, et al.
American Heart Journal|June 15, 2016
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) TrialYuichi J Shimada, Sameer Bansilal, Stephen D Wiviott, et al.
Diabetes, Obesity & Metabolism|May 19, 2022
Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysisChao Li, Jie Yu, Carinna Hockham, et al.
JACC. Cardiovascular Interventions|August 24, 2019
Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCIStefan H Hohnloser, Philippe Gabriel Steg, Jonas Oldgren, et al.
Circulation|June 3, 2004
The clinician as investigator: participating in clinical trials in the practice settingEllis W Lader, Christopher P Cannon, E Magnus Ohman, et al.
Critical Pathways in Cardiology|March 15, 2008
Assessing the effect of publication of clinical guidelines on the management of unstable angina and non-ST elevation myocardial infarction in the TIMI III (1990-1993) and the GUARANTEE (1995-1996) RegistriesBenjamin M Scirica, Christopher P Cannon, C Michael Gibson, et al.
Circulation|December 22, 1998
TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B InvestigatorsC P Cannon, C M Gibson, C H McCabe, et al.
American Heart Journal|January 8, 2025
Type 2 diabetes disease and management patterns across a large, diverse healthcare system: Issues and opportunities for guideline-directed therapiesAlexander J Blood, Lee-Shing Chang, Caitlin Colling, et al.
JAMA Cardiology|February 27, 2020
Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysisRenato D Lopes, Hwanhee Hong, Ralf E Harskamp, et al.
Journal of the American College of Cardiology|May 18, 2019
Familial Hypercholesterolemia Among Young Adults With Myocardial InfarctionAvinainder Singh, Ankur Gupta, Bradley L Collins, et al.
Pageof 94